Effects of pentoxifylline on central hemodynamics in patients with congestive heart failure
Autor: | Stig Ekeström, L Liljeqvist, O Nordhus |
---|---|
Rok vydání: | 1986 |
Předmět: |
Male
Cardiac output medicine.medical_specialty Heart disease Cardiac index Hemodynamics Blood Pressure Internal medicine medicine.artery medicine Humans Cardiac Output Pentoxifylline Aged Heart Failure business.industry Stroke Volume Stroke volume Middle Aged medicine.disease Myocardial Contraction medicine.anatomical_structure Heart failure Pulmonary artery Cardiology Vascular resistance Theobromine Female Vascular Resistance Cardiology and Cardiovascular Medicine business |
Zdroj: | Scandinavian Journal of Thoracic and Cardiovascular Surgery. 20:217-220 |
ISSN: | 0036-5580 |
DOI: | 10.3109/14017438609105927 |
Popis: | Pentoxifylline, a xanthine derivative with vasoactive and hemorheologic properties, was studied in regard to effect on central hemodynamics in ten patients with congestive heart failure due to aortic or mitral valve disease, mainly in NYHA group III or IV. The drug was infused intravenously in a dose of 4 mg/kg b.w. during a stable hemodynamic situation after valve replacement. The heart rate, systemic blood pressure, central venous and pulmonary artery pressures and cardiac output were recorded, and the stroke volume, cardiac index and systemic vascular resistance were calculated. Significant increase in cardiac output from the baseline value of 4.92 l/min was found 5-10 min (+22.6%) and 25-30 min (+19.5%) after pentoxifylline infusion. Cardiac index similarly increased from baseline, 2.73 dsc-5 (+22.3 and +18.3, respectively). The systemic vascular resistance showed significant decrease at the same intervals (-20.6 and -15.5%). The heart rate and stroke volume were significantly increased after 5-10 min. The systemic mean blood pressure and the pulmonary artery and central venous pressures showed no significant changes. There were no adverse effects of pentoxifylline. |
Databáze: | OpenAIRE |
Externí odkaz: |